75N91020F00021

CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	NIH NCI
NAICS	541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC	AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicle	75N91019D00024
Set-aside	Not reported
Pricing type	COST PLUS FIXED FEE
Obligations	$45.9M
Current contract value	$45.9M
Potential contract value / ceiling	$45.9M
Start date	Sep 25, 2020
Current end date	Aug 31, 2030
Potential end date	Aug 31, 2030
Latest award activity	Jun 17, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Jun 17, 2026	P00011	$3.7M	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Apr 9, 2026	P00010	$11.2M	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Sep 29, 2025	P00009	$3.2M	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Jul 21, 2025	P00008	$0	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
May 5, 2025	P00007	$5.6M	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Apr 27, 2023	P00006	$17.1M	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Jan 19, 2023	P00005	$904.8K	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Jun 30, 2022	P00004	$0	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Jun 14, 2022	P00003	$0	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Mar 8, 2022	P00002	$0	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Nov 30, 2021	P00001	$0	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM
Sep 25, 2020	0	$4.0M	CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM

Estimated positioning window

Aug 31, 2029 – Feb 28, 2030

Recompete signal:

45/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 45/100. Available recorded signals: 40 points.

Contract end 2030-08-31 (1399 days from calculation): +5 points
240 historical awards in this buyer and category group: +15 points
12 recorded award transactions: +10 points
Latest award action: 2026-06-17: +5 points
Parent award identifier recorded: +5 points
Solicitation identifier recorded: +0 points
Linked official forecast: +0 points
Calculated on: 2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Confirm the ordering vehicle and your eligibility or a qualified teaming route.
Review the award scope and buyer evidence before making a bid/no-bid decision.